# Vizol S DIGI EYE Efficacy and Safety Study in Patients With Dry Eye

> **NCT07050446** · PHASE3 · COMPLETED · sponsor: **Jadran Galenski laboratorij d.d.** · enrollment: 86 (actual)

## Conditions studied

- Dry Eye Disease (DED)

## Interventions

- **DRUG:** Vizol S DIGI EYE eye drops
- **DRUG:** 0,9% saline solution, eye drops

## Key facts

- **NCT ID:** NCT07050446
- **Lead sponsor:** Jadran Galenski laboratorij d.d.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-03-20
- **Primary completion:** 2024-08-23
- **Final completion:** 2024-11-02
- **Target enrollment:** 86 (ACTUAL)
- **Last updated:** 2025-07-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07050446

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07050446, "Vizol S DIGI EYE Efficacy and Safety Study in Patients With Dry Eye". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT07050446. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*